BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31997314)

  • 1. Report of the first patient with a homozygous OTUD7A variant responsible for epileptic encephalopathy and related proteasome dysfunction.
    Garret P; Ebstein F; Delplancq G; Dozieres-Puyravel B; Boughalem A; Auvin S; Duffourd Y; Klafack S; Zieba BA; Mahmoudi S; Singh KK; Duplomb L; Thauvin-Robinet C; Costa JM; Krüger E; Trost D; Verloes A; Faivre L; Vitobello A
    Clin Genet; 2020 Apr; 97(4):567-575. PubMed ID: 31997314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Otud7a Knockout Mice Recapitulate Many Neurological Features of 15q13.3 Microdeletion Syndrome.
    Yin J; Chen W; Chao ES; Soriano S; Wang L; Wang W; Cummock SE; Tao H; Pang K; Liu Z; Pereira FA; Samaco RC; Zoghbi HY; Xue M; Schaaf CP
    Am J Hum Genet; 2018 Feb; 102(2):296-308. PubMed ID: 29395075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic loss of OTUD7A causes severe muscular hypotonia, intellectual disability, and seizures.
    Suzuki H; Inaba M; Yamada M; Uehara T; Takenouchi T; Mizuno S; Kosaki K; Doi M
    Am J Med Genet A; 2021 Apr; 185(4):1182-1186. PubMed ID: 33381903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome.
    Uddin M; Unda BK; Kwan V; Holzapfel NT; White SH; Chalil L; Woodbury-Smith M; Ho KS; Harward E; Murtaza N; Dave B; Pellecchia G; D'Abate L; Nalpathamkalam T; Lamoureux S; Wei J; Speevak M; Stavropoulos J; Hope KJ; Doble BW; Nielsen J; Wassman ER; Scherer SW; Singh KK
    Am J Hum Genet; 2018 Feb; 102(2):278-295. PubMed ID: 29395074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15q13.3 homozygous knockout mouse model display epilepsy-, autism- and schizophrenia-related phenotypes.
    Forsingdal A; Fejgin K; Nielsen V; Werge T; Nielsen J
    Transl Psychiatry; 2016 Jul; 6(7):e860. PubMed ID: 27459725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A de novo nonsense mutation in ZBTB18 plus a de novo 15q13.3 microdeletion in a 6-year-old female.
    Ehmke N; Karge S; Buchmann J; Korinth D; Horn D; Reis O; Häßler F
    Am J Med Genet A; 2017 May; 173(5):1251-1256. PubMed ID: 28345786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide gene expression in a patient with 15q13.3 homozygous microdeletion syndrome.
    Le Pichon JB; Yu S; Kibiryeva N; Graf WD; Bittel DC
    Eur J Hum Genet; 2013 Oct; 21(10):1093-9. PubMed ID: 23361223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further delineation of eye manifestations in homozygous 15q13.3 microdeletions including TRPM1: a differential diagnosis of ceroid lipofuscinosis.
    Masurel-Paulet A; Drumare I; Holder M; Cuisset JM; Vallée L; Defoort S; Bourgois B; Pernes P; Cuvellier JC; Huet F; Chehadeh SE; Thevenon J; Callier P; Thauvin C; Faivre L; Andrieux J
    Am J Med Genet A; 2014 Jun; 164A(6):1537-44. PubMed ID: 24668847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse Model of Chromosome 15q13.3 Microdeletion Syndrome Demonstrates Features Related to Autism Spectrum Disorder.
    Kogan JH; Gross AK; Featherstone RE; Shin R; Chen Q; Heusner CL; Adachi M; Lin A; Walton NM; Miyoshi S; Miyake S; Tajinda K; Ito H; Siegel SJ; Matsumoto M
    J Neurosci; 2015 Dec; 35(49):16282-94. PubMed ID: 26658876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound heterozygous microdeletion of chromosome 15q13.3 region in a child with hypotonia, impaired vision, and global developmental delay.
    Prasun P; Hankerd M; Kristofice M; Scussel L; Sivaswamy L; Ebrahim S
    Am J Med Genet A; 2014 Jul; 164A(7):1815-20. PubMed ID: 24700535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small homozygous microdeletion of 15q13.3 including the CHRNA7 gene in a girl with a spectrum of severe neurodevelopmental features.
    Liao J; DeWard SJ; Madan-Khetarpal S; Surti U; Hu J
    Am J Med Genet A; 2011 Nov; 155A(11):2795-800. PubMed ID: 21990074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous deletion of chromosome 15q13.3 including CHRNA7 causes severe mental retardation, seizures, muscular hypotonia, and the loss of KLF13 and TRPM1 potentially cause macrocytosis and congenital retinal dysfunction in siblings.
    Spielmann M; Reichelt G; Hertzberg C; Trimborn M; Mundlos S; Horn D; Klopocki E
    Eur J Med Genet; 2011; 54(4):e441-5. PubMed ID: 21596161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype.
    Hoppman-Chaney N; Wain K; Seger PR; Superneau DW; Hodge JC
    Clin Genet; 2013 Apr; 83(4):345-51. PubMed ID: 22775350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Consequences of CHRNA7 Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells.
    Gillentine MA; Yin J; Bajic A; Zhang P; Cummock S; Kim JJ; Schaaf CP
    Am J Hum Genet; 2017 Dec; 101(6):874-887. PubMed ID: 29129316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13.3 microdeletion, encompassing CHRNA7.
    Gass N; Weber-Fahr W; Sartorius A; Becker R; Didriksen M; Stensbøl TB; Bastlund JF; Meyer-Lindenberg A; Schwarz AJ
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1150-60. PubMed ID: 27061851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mosaic 15q13.3 deletion including CHRNA7 gene in monozygotic twins.
    Popovici C; Busa T; Missirian C; Milh M; Moncla A; Philip N
    Eur J Med Genet; 2013 May; 56(5):274-7. PubMed ID: 23454271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central and peripheral immune responses to low-dose lipopolysaccharide in a mouse model of the 15q13.3 microdeletion.
    Halawa AA; Rees KA; McCamy KM; Winzer-Serhan UH
    Cytokine; 2020 Feb; 126():154879. PubMed ID: 31629107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iterative phenotyping of 15q11.2, 15q13.3 and 16p13.11 microdeletion carriers in pediatric epilepsies.
    Jähn JA; von Spiczak S; Muhle H; Obermeier T; Franke A; Mefford HC; Stephani U; Helbig I
    Epilepsy Res; 2014 Jan; 108(1):109-16. PubMed ID: 24246141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 15q13.3 deletion syndrome: Deficient α(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders.
    Deutsch SI; Burket JA; Benson AD; Urbano MR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():109-17. PubMed ID: 26257138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility gene card for: 15q13.3 microdeletion syndrome.
    Tropeano M; Andrieux J; Vassos E; Collier DA
    Eur J Hum Genet; 2014 Nov; 22(11):1338. PubMed ID: 24824131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.